HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
3.690
-0.150 (-3.91%)
Nov 7, 2024, 4:00 PM EST - Market closed
HOOKIPA Pharma Employees
As of December 31, 2023, HOOKIPA Pharma had 179 total employees, including 151 full-time and 28 part-time employees. The number of employees increased by 1 or 0.56% compared to the previous year.
Employees
179
Change (1Y)
1
Growth (1Y)
0.56%
Revenue / Employee
$291,413
Profits / Employee
-$271,486
Market Cap
44.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SHL Telemedicine | 583 |
Accelerate Diagnostics | 134 |
Vicarious Surgical | 131 |
Carisma Therapeutics | 107 |
CollPlant Biotechnologies | 75 |
Unicycive Therapeutics | 14 |
CalciMedica | 12 |
Serina Therapeutics | 11 |
HOOK News
- 7 days ago - HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 - GlobeNewsWire
- 8 days ago - HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer - GlobeNewsWire
- 6 weeks ago - HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - GlobeNewsWire
- 7 weeks ago - Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm - Business Wire
- 2 months ago - HOOKIPA Pharma Announces Board of Directors Changes - GlobeNewsWire
- 2 months ago - HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 - GlobeNewsWire